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A growing body of research is investigating the potential con-
tribution of mitochondrial function to the etiology of type 2
diabetes. Numerous in vitro, in situ, and in vivo methodologies
are available to examine various aspects of mitochondrial function,
each requiring an understanding of their principles, advantages,
and limitations. This review provides investigators with a critical
overview of the strengths, limitations and critical experimental
parameters to consider when selecting and conducting studies on
mitochondrial function. In vitro (isolated mitochondria) and in situ
(permeabilized cells/tissue) approaches provide direct access to
the mitochondria, allowing for study of mitochondrial bioenerget-
ics and redox function under defined substrate conditions. Several
experimental parameters must be tightly controlled, including
assay media, temperature, oxygen concentration, and in the case
of permeabilized skeletal muscle, the contractile state of the fibers.
Recently developed technology now offers the opportunity to
measure oxygen consumption in intact cultured cells. Magnetic
resonance spectroscopy provides the most direct way of assessing
mitochondrial function in vivo with interpretations based on spe-
cific modeling approaches. The continuing rapid evolution of these
technologies offers new and exciting opportunities for deciphering
the potential role of mitochondrial function in the etiology and
treatment of diabetes. Diabetes 62:1041–1053, 2013
T
here has been a dramatic expansion in research
investigating the role of mitochondria in the eti-
ology of type 2 diabetes. This trend has been
fueled, in part, by recent technological advances
for assessing mitochondrial function. The advent of new
tools and methodologies requires an understanding of the
potential advantages and limitations of each. Unfortu-
nately, relatively few consolidated resources are available
to introduce methodologies for assessing mitochondrial
bioenergetics—a field that focuses on direct and indirect
measures of ATP synthesis as well as redox and ion ho-
meostasis. While fundamentals of bioenergetics are cov-
ered elsewhere (1–3), the purpose of this review is to
provide an introduction to the principles, advantages,
and limitations to key methodologies used to study mito-
chondrial function in vitro, in situ, and in vivo. Our intent is
to assist in the selection of appropriate methodologies by
highlighting relevant characteristics of major approaches,
and to discuss recent issues in optimizing established
methodologies.
DEFINING AND MEASURING “MITOCHONDRIAL
FUNCTION”
The synthesis of ATP via oxidative phosphorylation is
the most common function ascribed to mitochondria. This
process is typically determined indirectly through mea-
surement of mitochondrial oxygen (O2) consumption, or
respiration. Hence, altered respiratory kinetics in response
to specific substrates are often interpreted as reflecting
changes in oxidative phosphorylation and the regulation of
cellular energy homeostasis in vivo. However, in addition
to ATP synthesis, mitochondria play a central role in es-
tablishing and regulating cellular redox homeostasis. The
present review provides an overview of the leading methods
used to examine both of these functions.
Respirometry. In 1956, Chance and Williams (4) pub-
lished the definitions of different respiratory steady-states
based on the typical order of substrate additions made
during an experiment on isolated mitochondria. These
definitions have since been modified by Nicholls and
Ferguson (2), reflecting an alternative sequence of sub-
strate additions used during many mitochondrial experi-
ments (Table 1). Under this system of nomenclature, state
1 refers to the O2 consumption rate of mitochondria alone
prior to addition of exogenous substrates or ADP. State 1
O2 consumption rate is minimal. Addition of substrate(s)
provides the fuel necessary to support the mitochondria,
generating an increase in O2 consumption (state 2) that
largely reflects the basal rate of proton conductance (i.e.,
leak) back into the mitochondrial matrix. State 3 refers to
the rate of respiration generated upon addition of ADP, and
therefore exceeds state 2. State 4 refers to the rate of res-
piration remaining after all ADP has been converted to
ATP. Although state 2 and state 4 respiration are empiri-
cally equivalent, state 4 is conventionally used when
referring to respiration under basal, nonphosphorylating con-
ditions. The respiratory control ratio, defined as the quotient
of maximal state 3 to state 4 respiration, is often used as an
index of mitochondrial coupling of oxidation (O2 con-
sumption) to phosphorylation of ADP to ATP, and thus the
functional integrity of mitochondrial preparations. Famil-
iarization with the development of these and other con-
ventions are strongly recommended by referring to several
key resources (1,2,4–9).
Measuring mitochondrial respiration. Measuring the
rate of mitochondrial respirometric O2 flux is accom-
plished by a number of methods, including O2-dependent
quenching of porphyrin-based phosphors (10) and amper-
ometric O2 sensors (7). Although phosphorescent probes
are growing in use for in vitro/in situ respiratory mea-
surements (e.g., the Seahorse Bioscience XF Extracellular
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Flux Analyzer or Luxcel MitoXpress) and are particularly
useful for in vivo estimates of O2 consumption in cultured
cells (11), the amperometric approach has historically been
the most common for in vitro investigations of mitochon-
drial respiration. The Clark electrode contains a gold or
platinum cathode and an Ag/AgCl anode separated by
a KCl solution. A voltage is applied to the two half-cells,
which are separated from the experimental assay media by
a membrane of O2-permeant material (e.g., polyvinylidene
difluoride). O2 diffuses from the assay media through the
membrane and is reduced by electrons at the cathode,
yielding hydrogen peroxide (H2O2). The H2O2 then oxidizes
the Ag of the Ag/AgCl anode, which generates an electrical
current proportional to the partial pressure, and in turn con-
centration, of O2 in the experimental solution (7). Changes
in [O2] in the assay media (typically 1–2 mL) therefore cor-
respond to the inverse of the respiratory rate of a biological
sample (e.g., mitochondria) and allow for quantification of
O2 consumption (7).
The introduction of the XF Extracellular Flux Analyzer
(Seahorse Bioscience) in 2006 represented a technical
breakthrough for the field of bioenergetics by providing the
first instrument with the capacity to measure in vivo O2
consumption in intact adherent cells in culture. The system
uses a 24- or 96-well cell culture microplate format that is
mated from above with a sensor cartridge containing an
equivalent number of individual probes, each containing flu-
orophores sensitive to O2 or H
1 embedded within the poly-
mer that comprises the probe. This piston-like sensor
cartridge is introduced periodically into the wells of the mi-
croplate, forming transient microchambers just above (;200
microns) the cell monolayer. Fiber optic bundles inserted
simultaneously by the machine into the probes of the sensor
cartridge provide the excitation and collect the emission light
for each fluorophore. The change in O2 and H
1 concentration
in the media (7–10 mL) is measured over several minutes,
reflecting the rate of cellular O2 consumption and H
1 pro-
duction. Raising the sensor cartridge then allows the media
above the cells to mix/reequilibrate. The XF Extracellular
Flux Analyzer can also measure extracellular acidification
rates and carbon dioxide evolution rates as indices of gly-
colysis and tricarboxylic acid cycle (TCA) kinetics.
Technical considerations and limitations. Accurate
amperometric measurement of O2 consumption is best
achieved through high-resolution respirometric systems in-
corporating materials and structural designs that provide
minimal O2 leak and maximal sensitivity to O2. To this end,
manufacturers of respirometric systems (e.g., OROBOROS
Instruments, Strathkelvin Instruments, Hansatech Instru-
ments, etc.) incorporate 1) closed, air-tight reaction cham-
bers; 2) glass and/or low O2-permeable polymers comprising
all components (chamber seals, stir bars, etc), which mini-
mizes O2 back-diffusion and over-estimations of respiration;
and 3) sensors capable of detecting changes in [O2] with
minimal noise. High resolution designs (i.e., O2k, ORO-
BOROS Instruments) maximize respirometric sensitivity
and precision (minimal O2 leak and highly sensitive elec-
trodes), reducing the biological sample size required. Soft-
ware advances in flux derivations of changes in chamber
PO2 also permit real-time reporting of respiratory kinetics
(Datlab, OROBOROS Instruments), which improves data
analyses over other systems requiring visual assessments
of steady-state kinetics. Moreover, the unavoidable back-
ground O2 consumption by the electrode itself, combined
with varying degrees of O2 back-diffusion into the oxy-
graphic chamber, constitute potential sources of systematic
error. In high-resolution systems, global instrumental back-
ground O2 consumption (i.e., nonbiological O2 flux), which
increases positively as a function of PO2, must be corrected
for accurate determinations of absolute O2 consumption.
All amperometric-based approaches are suitable for
studying isolated mitochondria, permeabilized cells/tissue
and/or intact cells in suspension. Most provide injection
ports and/or infusion systems for introducing substrates,
reagents, and/or inhibitors without exposing the chamber
solution to ambient O2. Units with peltier control of tem-
perature permit comparisons of functional kinetics at
precise temperatures, a critical parameter (see “Control-
ling critical experimental parameters: temperature”), but
this is not available in all systems. In addition, the capa-
bility of the O2k system (OROBOROS Instruments) has
recently expanded beyond respiration to permit simulta-
neous fluorescence-based measurements, potentiometric
measurements of H1 (i.e., pH), triphenylphosphonium
(membrane potential probe), and Ca21, as well as amper-
ometric measurement of nitric oxide. High stirring
capacities (i.e., several hundred rpm) in all closed systems
prevent gradients from forming between the biological
source in solution (i.e., isolated mitochondria, per-
meabilized tissue/cells, etc.) and the detector(s). Posi-
tioning the O2 electrode at a 45° angle relative to the
bottom of the chamber (e.g., O2k) also insures stirring
about the electrode is optimized (7). Sample stirring also
ensures maximal exposure of tissue surface area to the
surrounding assay media, which is critical for optimizing
diffusion of substrates and O2 to sample cores. However,
TABLE 1
A comparison of the respiratory steady-state conventions
Author(s)
Respiration
terminology Relative O2 flux Characteristics
Chance and
Williams (4) State 1 Negligible Mitochondria alone
State 2 Negligible or low ADP added, low/no substrate*
State 3 High ADP present, substrate added
State 4 Low Low ADP (converted to ATP), substrate present
State 5 Negligible Oxygen depleted from experimental chamber
Gnaiger (130) LEAK Low Maximal substrate, no ADP
OXPHOS High Maximal ADP and substrate
ETS Very high Maximal substrate, uncoupler present
*State 2 defined as “substrate present, ADP low” by Nicholls and Ferguson (2). ETS, electron transport system; LEAK, respiration due to basal
proton conductance across the inner mitochondrial membrane; OXPHOS, oxidative phosphorylation.
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as most cell culture–based studies are conducted on ad-
herent cells, the utility of solution-based systems is ob-
viously limited when the experimental objective is to
assess cellular bioenergetics in intact cultured cells. The
effect(s), per se, of rapid stirring on the function of either
isolated mitochondria or permeabilized fibers and cells has
not, to our knowledge, been systematically tested. How-
ever, it has been noted that with the gentle stirring involved
in the preparation of saponin-permeabilized human skeletal
muscle fibers, less than 4% of total citrate synthase is lib-
erated in both the permeabilization and wash steps (12).
As described above, the XF Extracellular Flux Analyzer
(Seahorse Bioscience) minimizes the potential limitation
for adherent cells by transiently limiting the volume of
solution in which O2 and H
1 are measured to just above
the monolayer of cultured cells. However, this temporary
microenvironment is not completely isolated from atmo-
spheric O2 because of the potential for exchange with the
surrounding media (i.e., the piston-like sensor probes do
not form a seal when lowered into the well) and the plastic
comprising the microplate wells (i.e., polystyrene is per-
meable to O2 [13,14]). Consequently, as [O2] declines in the
chamber volume above the cells during longer measure-
ment periods, a gradient is created favoring diffusion of O2
from the media surrounding the sensor probe and the walls
of the well into the measurement volume. This counteracts
declines in assay [O2] due to respiration leading to an un-
derestimation of cellular respiration rate. Likewise, in pro-
tocols in which anoxia is reached and the media is then
reoxygenated by mixing, diffusion of O2 back into the de-
pleted chamber from the chamber walls can lead to over-
estimation of low rates during the subsequent measurement
period. This limitation has been addressed through the de-
velopment of a compartment-model–based algorithm to
account for both sources of O2 diffusion (15).
Aside from the obvious biological relevance of assessing
bioenergetic function in intact cells, the XF Extracellular
Flux Analyzer offers a much higher throughput platform
than the traditional Clark electrode-based systems. This is
advantageous for screening-based applications; e.g., screen-
ing drug candidates for potential mitochondrial toxicity.
Since its introduction, the XF Extracellular Flux Analyzer has
been validated for a variety of different cell types (16–20),
including single muscle fibers (21). However, many sub-
strates and compounds used to target specific mitochondrial
pathways do not cross the cell membrane. Therefore, tar-
geted probing of potential changes in mitochondrial function
often requires gaining direct access to mitochondria, either
via permeabilization or by isolating mitochondria. Because of
their versatility and expanding capabilities, amperometric-
based closed systems have historically been the method of
choice for isolated mitochondria or permeabilized cells/
tissue. However, if high throughput is needed, the XF Ex-
tracellular Flux Analyzer may be used by adhering mito-
chondria to the bottom of the microplate with a brief
centrifugation step (19). No specific coating of the microplate
is required, and the mitochondria remain attached through
repeated mixing/measuring cycles. Care must be taken not to
overload the wells, which can cause O2 to quickly become
depleted under state 3 conditions. Substrates (e.g., ADP, etc.)
may also become depleted from the small microchamber
volume (7 mL) and thus be rate limiting. Similar to the situ-
ation with O2, although the chamber is semiopen, rates of
substrate utilization by the plated mitochondria may exceed
the diffusion capacity from the media surrounding the
microchamber, necessitating the testing and use of higher
initial substrate concentrations than typically required in
closed systems that are not limited by volume or diffusion
(19). Use of permeabilized muscle fiber bundles has not
been validated in the XF Extracellular Flux Analyzer.
Oxidant emission. Another key function of mitochondria
is the regulation of cellular redox homeostasis through the
establishment of the redox circuitry (e.g., via the NADPH/
NADP couple) and emission of reactive oxidants. The re-
dox circuitry extends throughout the proteome and rep-
resents a major mechanism of controlling multiple cell
functions (22–24). This has particular relevance to the
study of metabolic health given that oxidant emission
(oxidant production minus oxidant scavenging) and redox
signaling have been implicated in the etiology of insulin
resistance in multiple tissues, including skeletal muscle
(reviewed in 3,25–27).
Reactive O2 species (ROS) is an umbrella term used to
describe molecules that are chemically reactive due to the
incomplete reduction of O2 within the molecule. These
include free radicals possessing an unpaired electron such
as the superoxide anion (O2$2), hydroxyl radical (HO$),
peroxyl and nitroxyl radicals, as well as nonradical oxi-
dants such as H2O2 (22). However, the term oxidants
generally encompasses ROS, reactive nitrogen species,
and reactive lipid species (26,28,29). Because of their rel-
ative instability, oxidants are generally quite difficult to
study, a fact highlighted by the historical lack of widely
available tools to measure oxidants (30). Electron spin
resonance/electron paramagnetic resonance represents
the most direct way to detect free radicals, an approach
that can be used in vivo under physiological conditions
(31,32). A variation on the technique, known as spin
trapping, is also frequently used; it incorporates a detect-
ing molecule that reacts with, but is considerably more
stable than, the initial free radical. The resulting free rad-
ical product often has spectral properties that allow the
original radical to be identified indirectly. Although clinical
applications continue to develop (33), in general electron
spin resonance/electron paramagnetic resonance spec-
troscopy is limited in both its specificity and sensitivity to
quantitatively detect free radicals typically associated with
biological systems (31,32). Furthermore, this method does
not detect nonradical oxidants.
Several fluorescent-, chemiluminescent-, and, most re-
cently, electrochemical/nanoparticle-based (34) approaches
are available to detect oxidants. Fluorescent probes are
arguably the most common method used to detect a vari-
ety of oxidants (35). For example, oxidation of the widely
used 29,79-dichlorodihydrofluorescein can give a sense of
ROS burst. However, dichlorodihydrofluorescein is noto-
rious for its relative lack of specificity and is subject to
auto-oxidation and photo-oxidation (36). Mitochondrial
O2$2, the parent molecule of all ROS, can be detected flu-
orescently by the mitochondrial-targeted triphenylphospho-
nium hydroethidine-based probe MitoSOX Red (Invitrogen)
(37). However, MitoSOX Red also reacts with other oxidant
species to generate products with overlapping emission
spectra, although this limitation can be overcome through
use of an alternative detection system based on capillary
electrophoresis (38,39). In biological systems however, mi-
tochondrial O2$2 is rapidly and efficiently converted by man-
ganese superoxide dismutase to H2O2, a membrane-permeable
nonradical oxidant recognized for its role as a biological sec-
ond messenger (22,30,40–42).
First described by Mohanty et al. (43), the redox-sensitive
fluorogenic AmplexRed (N-acetyl-3,7-dihydroxyphenoxazine)
C.G.R. PERRY AND ASSOCIATES
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has become the most commonly used reagent for detecting
H2O2 in the past ten years. Unlike its predecessor scopole-
tin, AmplexRed (and the latest AmplexUltraRed) is a col-
orless and nonfluorescent derivative of dihydroresorufin,
which is oxidized by H2O2 via horseradish peroxidase (1:1
reaction stoichiometry) to the highly fluorescent resorufin
(44). A number of ratiometric- as well as genetic-based
fluorescent probes with high specificity for H2O2 have re-
cently been developed for use in living cells, including
sensors that are targeted to various cellular locations (45–
48). These tools provide unprecedented ability to visualize
by confocal microscopy in real time the spatiotemporal
nature of cellular H2O2 production and its impact on local
redox environments.
Measuring mitochondrial oxidant emission potential.
Measuring mitochondrial oxidant production has been ac-
complished using isolated mitochondria or permeabilized
cells/tissue. The method is based on the general principle
that the mitochondrial respiratory chain is a redox system
reflecting the balance between the reducing potential of
redox couples feeding into and through the system and the
rate of proton conductance across the mitochondrial inner
membrane into the matrix (2,3). Reducing potential within
the electron transport system can be raised by increasing
the supply and/or blocking the flow of electrons (e.g., with
specific inhibitors), creating conditions that lead to electron
leak and O2$2 generation, and in turn H2O2. H2O2 is un-
charged and therefore freely diffuses out of the mitochon-
drial matrix, possibly facilitated by aquaporin channels (49),
where it can be measured by one of the detection systems
mentioned above. Various substrates in combination with
inhibitors to specific sites within the respiratory complexes
have been used to identify the sites and topology of O2$2
production (50–52). It is important to recognize that both
glutathione and thioredoxin provide significant H2O2 scav-
enging capacity in the mitochondrial matrix (21,27); thus,
the emission rate of H2O2 from the mitochondria reflects the
balance between H2O2 production and scavenging rates and
therefore underestimates the rate of O2$2 production (44,45).
Mitochondrial glutathione can be depleted by pretreatment
with oxidizing agents such as 1-chloro-2,4,-dinitrobenzene to
obtain a more accurate measure of O2$2 production (ap-
proximately twofold higher rate of H2O2 emission by mito-
chondria) (53). It is important to note that measures of
H2O2 emission in permeabilized cells or isolated preparations
are performed under substrate and respiratory conditions
that are defined experimentally but do not and cannot per-
fectly replicate conditions in vivo. Thus, these represent
estimates of the mitochondrial oxidant emitting potential
(54) of the preparation under the experimental conditions
chosen.
Measurement of membrane potential. Membrane po-
tential across the inner membrane is a critical parameter
in the study of overall mitochondrial function because it
represents the balance between reduction potential of the
proton pumps in the electron transport system and the rate
of ion conductance (e.g., H1) back across the membrane
into the matrix. In essence, it reflects the redox state of the
system and therefore the tendency of electrons to leak to
O2 to form O2$2. A number of cationic fluorescent probes
have been developed for assessing qualitative changes in
mitochondrial membrane potential in cultured cells using
both confocal microscopy and flow cytometry (55,56).
Quantitative measures of membrane potential have typically
been performed on isolated mitochondria using elec-
trodes sensitive to potential-dependent probes such as
triphenylmethyl phosphonium cation (1,2). Calculation of
membrane potential is based on the Nernst equation and
requires an estimate of the matrix volume (per unit pro-
tein) over which the probe distributes.
ATP production via bioluminescence. ATP production
rate has been used to provide an index of oxidative phos-
phorylation activity in isolated mitochondria. The ATP
produced is detected through the reaction of luciferin with
ATP to ultimately generate oxyluciferin, AMP, and light via
firefly luciferase, which is detected in a luminometer (57).
This method is typically performed on isolated mitochon-
dria and provides a direct measure of ATP production
rate rather than relying on the assumption that all ADP
added is phosphorylated. This is particularly advantageous
if a given experimental treatment may change coupling
efficiencies (P/O ratios, reflecting the amount of ATP
produced per O2 reduced to water during oxidative phos-
phorylation). Hence, a given respiration rate would no
longer represent a specific rate of ATP production ren-
dering conclusions regarding ATP synthesis quite difficult
based on respiratory kinetics alone. A more detailed over-
view of this methodology is reviewed elsewhere (57).
Calcium retention capacity. The sensitivity of the per-
meability transition pore to calcium loading has been used
as an index of mitochondrial viability and can be evalu-
ated by determining the calcium retention capacity of mito-
chondria to Calcium Green-5N (Molecular Probes), a relatively
low-affinity impermeable calcium indicator that exhibits an
increase in fluorescence emission intensity upon binding cal-
cium. Pulses of calcium are added at defined intervals, each
eliciting a spike in signal that quickly dissipates due to the
uptake of calcium into the mitochondrial matrix. Calcium
concentration is monitored continuously with each addition
until opening of the Permeability Transition Pore collapses the
membrane potential and releases the accumulated calcium
from the matrix, causing a sudden and sustained increase in
signal. The amount of calcium retained prior to opening of the
Permeability Transition Pore is considered an index of mito-
chondrial viability, particularly in the context of ischemia-
reperfusion injury in the heart (58–60).
SAMPLE PREPARATIONS: IN VITRO AND IN SITU
APPROACHES
Isolated mitochondria. Isolation of mitochondria through
tissue/cell culture homogenization and differential centri-
fugation is routinely used for assessments of mitochondrial
O2 consumption, oxidant emission, and membrane potential
in a variety of tissues (1,61–65). This preparation is ideal for
studying mitochondrial bioenergetics free from the in-
fluence of other cellular factors (e.g., cytoskeleton and en-
doplasmic reticulum). However, comparisons of isolated
mitochondria to permeabilized muscle fiber bundles can be
a powerful approach for isolating the effects of cytosolic
structures in regulating mitochondrial function as high-
lighted previously (54,66–69). It also permits assessments
of distinct subcellular pools of mitochondria, specifically
subsarcolemmal and intermyofibrillar fractions of skeletal
muscle, which appear to have unique functional properties
(70). However, the disadvantages of the isolated mito-
chondria approach (described in ref. 62) include 1) disrup-
tion of mitochondrial structure, which may impact function,
especially if fused into a continuous reticulum such as in
mature skeletal muscle (62,69,71–75); 2) biased selection of
certain mitochondrial populations in a given sample (e.g.,
less dense mitochondrial populations excluded from the
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differential centrifugation step) (62,74); 3) requirement of
relatively large sample sizes (.200$106 cells, or$100–150 mg
wet weight of tissue) to generate sufficient mitochondrial
yields, which at best often amount to ,20% of the total
population (61,62); and 4) loss of mitochondrial interactions
with other cellular components, thus altering the functional
properties (i.e., microcompartmentalization, metabolic chan-
neling, and intracellular energy transfer) known to be present
in vivo (62,76–79).
Permeabilized tissue. The scope within which mito-
chondrial functions can be analyzed in vivo is limited due
to the fact that many exogenously added treatments (e.g.,
effectors such as ADP) do not readily penetrate cell
membranes (62). Efforts to both circumvent the limitations
associated with isolated mitochondrial preparations, and
at the same time maintain the experimental freedoms con-
ferred by the methodology, have lead to established pro-
tocols involving chemically permeabilized cells (80). This
method has also been adapted to assess mitochondria in
multiple tissue types including cardiac muscle fibers (62,81),
hepatocytes (82), adipose tissue (83,84), and especially
skeletal muscle (62), although the application of this ap-
proach in each tissue requires careful consideration of
unique limitations such as the ability to remove endoge-
nous substrates following permeabilization. The success-
ful permeabilization of cell membranes is achieved by
cholesterol-specific detergents such as digitonin, filipin,
a-solanine, a-tomatine, and b-escin (62). One of the most
widely used permeabilizing agents is quillaja saponin, a rel-
atively mild detergent (e.g., compared with digitonin [85])
derived from the soap bark tree (Quillaja saponaria) and
referred to in the literature as simply saponin.
Saponins owe their detergent properties to hydrophilic
glycoside moieties attached to lipophilic triterpene deriv-
atives (86), which gives saponin its high affinity for
cholesterol (62). Because plasma membranes contain ap-
proximately seven times more cholesterol (;0.5 mol
cholesterol per mol phospholipid) than mitochondria (0.07
and 0.01 mol cholesterol per mol phospholipid for the
mitochondrial outer and inner membranes, respectively)
(87,88), very small concentrations of saponin (e.g., up to 50
mg$mL21) are sufficient to selectively permeabilize the
plasma membrane (62). Pores ;8 nm in diameter are
formed, providing an effective “washout” of soluble cyto-
solic contents and allowing direct access of exogenously
added substrates/reagents to the mitochondria (89,90).
Additional intracellular structures containing little or no
cholesterol, such as the sarcoplasmic reticulum (SR) and
the contractile apparatus will also remain intact upon sa-
ponin treatment (78). Furthermore, saponin concentra-
tions as low as 50 mg$mL21 have been shown to increase
Ca12 loss from the SR of mammalian cardiac and skeletal
muscle (91,92) and to also reduce the ability of the SR to
load Ca12 (90). This is thought to result from the effect of
saponin on the SR Ca12 release channels, and not SR
membrane permeabilization, per se (90). Because mito-
chondria are known to readily take up Ca12 (93), the loss
of Ca12 from the SR during permeabilization is beneficial
to studies involving mitochondrial function. Furthermore,
normal mitochondrial morphology, including intact inner
and outer mitochondrial membranes, has been verified by
electron microscopy in saponin-permeabilized cardiac
fibers due to a low abundance of cholesterol in these
membranes (62,81). Mitochondrial integrity is often verified
by adding exogenous cytochrome c, such that any addi-
tional increase in respiration is indicative of a disrupted
outer membrane (94). A common practice is to accept up to
10% increases in respiration upon addition of cytochrome c
as evidence of preserved integrity, although this has yet to
be validated. Indeed, it has been shown that isolated mito-
chondria can lose cytochrome c independent of outer
membrane intactness (95). There is also evidence that
a cytochrome c effect may depend on the substrates used
to support respiration, although the reasons for this ob-
servation are not entirely clear (96,97). Moreover, it has
been suggested that cytochrome c release into the cytosol
in vivo is sufficient to maintain oxidative phosphorylation
(96,98). In saponin-permeabilized cardiac fibers, the results
of a cytochrome c test have even been noted to depend on
the respiratory steady-state, with mitochondria in state 4
exhibiting greater cytochrome c responses than those in
state 3 (97). There is an apparent paucity of studies in which
the cytochrome c test is performed on isolated mito-
chondria, and those having reported the test results tend
to indicate an increase in respiration after cytochrome
c addition (99,100). Our own experience suggests that at
37°C, a cytochrome c response is unavoidable in mito-
chondria isolated from rat skeletal muscle using standard
procedures (unpublished observations by D.A.K.). Thus, the
cytochrome c test represents a convenient, but clearly
imperfect means of testing for outer mitochondrial mem-
brane intactness. When the objective is to establish the
intactness of the mitochondria independent of the re-
search hypothesis, the cytochrome c test should be per-
formed during state 3 respiration.
When compared with isolated mitochondria, the advan-
tages of the permeabilized fiber approach to study muscle
mitochondria (described in 62) include 1) retention of the
mitochondrial reticular morphology (66), 2) retention of
potential interactions between mitochondria and other
subcellular structures/organelles (cytoskeleton, contractile
proteins, peroxisomes, endoplasmic reticulum, etc.) (67),
and 3) small sample size (1–2 mg wet weight). Limitations
include 1) the requirement for fresh tissue, although
cryogenic freezing with glycerol-based media to prevent
membrane rupturing has been reported (101)—but with
limited effectiveness following long-term preservation
(102); 2) the potential for diffusion limitations of O2 and
substrates to the mitochondria; 3) the potential for
nonmitochondrial-specific cationic probe distribution
used in membrane potential measurements; 4) the pro-
pensity for permeabilized muscle fibers to contract in re-
sponse to ADP (54,103); and 5) challenges in normalizing
data to mitochondrial content. Regarding the latter, recent
evidence suggests it may be possible to quantify mito-
chondria using protein densitometry in lyophilized sam-
ples postexperiment (104) or perhaps mitochondrial DNA
or enzyme activities. However, the marker for mitochon-
drial content must be carefully considered, as not all
markers have been shown to strongly correlate with total
mitochondrial content (105). Furthermore, standard con-
vention is to express functional data to wet weight, which
is often recorded prior to an experiment, or dry weight,
which requires retrieval of tissue sample from the reaction
vessel. Dry weights avoid the inconsistencies in water con-
tribution to total weight. However, blotting and weighing
wet permeabilized muscle fibers prior to experimenta-
tion may affect certain respiratory metrics, particularly
the apparent Km to ADP (Kmapp), which may be due to
contraction in the absence of relaxing solution during
weighing (unpublished observations by C.G.R.P. in rodent
and human skeletal muscle). Certain tissues are prone to
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disintegration during functional assessments in systems
with stirring, although this is prevented by myosin ATPase
inhibition in the case of skeletal muscle (54).
Cultured cells. Cultured cells provide several advantages,
including the obvious relevance to in vivo biology, the
ability to manipulate the expression of proteins of interest,
and the ability to apply optical imaging of subcellular
compartment-specific fluorophores targeted to specific
proteins or biochemical signal generation. However, most
immortalized cell lines are metabolically adapted for rapid
growth, often require culture conditions that are nonphy-
siological (i.e., up to 25 mmol/L glucose), and derive most
of their energy from glycolysis rather than mitochondrial
oxidative phosphorylation (106,107). Primary cells in cul-
ture possess more physiologically relevant metabolic poise
but are short lived and more technically challenging. Fur-
thermore, care must be taken when interpreting O2 con-
sumption data, given that mitochondrial bioenergetics,
regardless of the cell type used, is governed primarily by
cellular energy demand.
CONTROLLING CRITICAL EXPERIMENTAL PARAMETERS
A number of experimental parameters can affect mitochon-
drial function and should be considered when designing
experiments or clinical diagnostic tests. These include the
composition of the respiration buffer, reaction tempera-
ture, O2 concentration, and factors specific to working
with permeabilized cells/tissues.
Respiration buffer. The goal of most in vitro or in situ
studies is to replicate, as much as possible, the environ-
ment of mitochondria in vivo. To this end, assay media
have been designed to control the concentration of spe-
cific ions and total osmolarity reflective of extracellular
and intracellular conditions (Table 2). Isolated mitochon-
dria are generally prepared in media rich in sucrose, a mi-
tochondrial inner membrane–impermeant osmolite, which
is intended to promote stabilization of mitochondrial in-
tegrity (108,109). With permeabilized muscle fiber bundles,
separation and permeabilization is achieved in the K1
-based buffer (BIOPS [81]) or similar buffers with slight
modifications (62,110). Respiration buffers are generally
high K1-based media with physiological osmolarities
(;295 mOsm) that differ largely with respect to sucrose
and other stabilizing agents (54,62,110–112).
A special consideration of creatine and phosphocreatine
(PCr) concentrations is required for the assessment of ADP-
stimulated respiratory kinetics. Energy exchange (ADP/ATP)
between matrix and cytosolic compartments can occur
through creatine-dependent and -independent mechanisms.
Optimal exchange is achieved by phosphate shuttling from
matrix-derived ATP to creatine via mitochondrial creatine
kinase in the intermembrane space with the PCr product
then exported to the cytosol (113). This mechanism is de-
pressed by PCr concentrations typical of relaxed skeletal
muscle in vivo (54,114). In the absence of creatine, energy
exchange is believed to occur less efficiently through direct
ADP/ATP transport/diffusion across both mitochondrial
membranes (66,113–117). The importance of supplementing
assay media with creatine and PCr to control phosphate
shuttling must therefore be considered when designing
respirometric protocols.
Temperature. Historically, in vitro and in situ studies of
mitochondrial function have typically been performed at
22–30°C for convenience and to maximize the duration of
the experiment before O2 becomes rate limiting. One might
assume that respiratory fluxes measured at lower tem-
peratures may be corrected to 37°C based on the Q10 effect
(respiration doubles for every 10°C increase). However,
the respiratory system represents a balance between op-
posing forces (i.e., reducing potential of the electron trans-
port system driving proton pumping verses the membrane
potential across the inner membrane), and therefore the
influence of temperature may not be as straightforward.
Indeed, this problem has been addressed for biological
systems in general (118). Data using permeabilized skeletal
muscle fibers indicate that the actual temperature coef-
ficients between respiration data obtained at 25°C or 30°C
versus 37°C are much lower than 2, meaning decreasing
temperature does tend to reduce respiration but the effect
is much less than predicted (54). A Q10 of less than 10 has
also been reported in isolated mitochondria (119,120),
which may suggest the diminished Q10 effect relative to in
vitro extraction-based determinations is due to properties
within mitochondria rather than to mitochondrial mor-
phology or the extramitochondrial environment that is
largely retained in permeabilized muscle. In fact, increased
stability of membranes and/or decreased ATPase activity
have been suggested as potential factors to account for the
lower rates of respiration at lower temperatures (121,122).
Interestingly, isolated mitochondrial H2O2 emission has
been demonstrated to increase or decrease with tempera-
ture, depending on the species and tissue source (121,123).
Thus, reaction temperature must be considered when de-
signing experiments as the practical advantages of con-
ducting experiments at lower temperature may compromise
extrapolation of findings to physiological temperature.
Permeabilized fiber bundles: contractile state. Al-
though not widely reported, permeabilized muscle fiber
bundles tend to spontaneously contract, particularly in
response to exogenous additions of ADP in a temperature-
sensitive manner (54). This is potentially problematic
as contraction may augment diffusion limitations for sub-
strates and O2. Fortunately, contraction may be preven-
ted through the use of nonspecific (e.g., pyrophosphate)
(124,125) or specific (e.g., blebbistatin, N-benzyltoluene
sulphonamide) (126,127) myosin ATPase inhibitors. In
fact, direct comparison of respiratory kinetics in relaxed
versus contracted fibers has revealed that contraction can
TABLE 2
Composition of preparation and respiration buffers for assessing
mitochondrial respiratory kinetics in permeabilized muscle fiber







EGTA 1 mmol/L 0.5 mmol/L 0.5 mmol/L
Taurine 0 20 mmol/L 20 mmol/L
Dithiothreitol 0 0.5 mmol/L 0
MgCl2 5 mmol/L 3 mmol/L 3 mmol/L
Sucrose 0 110 mmol/L 110 mmol/L
K-MES 105 mmol/L 0 0
KCl 30 mmol/L 0 0
K-lactobionate 0 60 mmol/L 60 mmol/L
KH2PO4 10 mmol/L 3 mmol/L 10 mmol/L
K-HEPES 0 20 mmol/L 20 mmol/L
Bovine serum
albumin 5.0 mg/mL 2.0 mg/mL 1 mg/mL
Leupeptin 0 1 mmol/L 0
Soybean trypsin
inhibitor 0 1 mmol/L 0
pH 7.1 7.1 7.1
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dramatically increase both the sensitivity (lower Kmapp) and
maximal responsiveness (Vmax) to ADP, depending on the
muscle type and species (54,128). Disruptions in the in-
teraction between the voltage-dependent anion channel,
which participates in regulating ADP/ATP flux in and out of
the mitochondria, with the cytoskeletal protein tubulin has
recently been suggested as a mechanism by which con-
traction may alter mitochondrial ADP permeability (67).
This is particularly intriguing, as it would represent a phys-
ical mechanism for increasing the sensitivity of the mito-
chondria to ADP at a time when it is most needed.
In the context of an experimental system however, ex-
actly what causes permeabilized fibers to contract in the
absence of added ADP/ATP is unresolved. Neither in-
hibition of potential cycling of residual endogenous ADP/
ATP between creatine kinase and myosin-ATPase, nor
limiting exposure to calcium (i.e., inclusion of high con-
centrations of the Ca21-chelator EGTA up to 5 mmol/L)
prevents the spontaneous contraction (54), suggesting that
the effect is independent of endogenous adenine nucleotide
cycling or calcium. Treatment with trypsin induces a similar
rapid shortening of permeabilized cardiomyocytes due to
degradation of the cytoskeleton (68), leading Kuznetsov
et al. (129) to raise the intriguing possibility that the pres-
ence of endogenous proteases may account for the ap-
parent calcium-independent contraction in permeabilized
muscle fibers. We recently tested this possibility in both
rodent (Fig. 1) and human (115) permeabilized skeletal
muscle fiber bundles treated with protease inhibitors in
three different respiration buffers, including Mitomed
as recommended by Kuznetsov et al. (129). Inclusion of
leupeptin, soybean trypsin inhibitor, and/or a protease in-
hibitor cocktail did not prevent contraction (see supple-
mentary videos in ref. 115) nor the contraction-induced
increase in respiratory sensitivity to ADP (i.e., lower
Kmapp, Fig. 1). Thus, proteolytic degradation of the cyto-
skeleton does not appear to account for the spontaneous
contraction. This leaves residual myosin-ATPase as the
most likely explanation at this time (54), possibly related
to rigor resulting from washout of ATP (103), although
clearly further work is needed.
Oxygen concentration. It has been reported that O2 at air
saturation (;220 mmol/L) rapidly becomes limiting to
respiration in permeabilized muscle fibers due to diffusion
limitations that are not present in cultured cells and isolated
mitochondria in solution (130–132). This has prompted the
practice of raising the initial O2 concentration in the respi-
ration chamber to above air saturation (300–500 mmol/L)
(133,134), which provides an additional benefit of avoiding
frequent resupplementation of oxygen into the chamber
during an experiment. A more recent study directly com-
paring air saturation (;150–220 mmol/L) with hyperoxia
(275–450 mmol/L) failed to find any difference in maximal
ADP-stimulated respiration in rodent red or white per-
meabilized muscle fiber bundles at 30°C or 37°C in high K1
respiration buffer (Buffer Z) (54). Surprisingly, the lack of
FIG. 1. The effect of protease inhibition or addition on contraction-mediated alterations in respiratory kinetics for ADP in Sprague-Dawley rat
permeabilized red gastrocnemius fiber bundles. A and B: Michaelis-Menten–type line-fitting curves of respiratory O2 flux (JO2) in permeabilized
muscle bundles, with 5 mmol/L pyruvate 1 2 mmol/L malate, as a function of ADP concentration with the myosin II inhibitor blebbistatin (BLEB, 25
mmol/L), representing relaxed fibers, or vehicle (DMSO), representing contracted fibers, in two common respirometric assay media (Buffer Z
[54,110,173] and Mitomed [129]). Protease inhibitors (1 mmol/L leupeptin and soybean trypsin inhibitor [STI]) were included in wash and assay
buffers. C: BLEB prevented the contraction-mediated (DMSO; spontaneous contraction) increase in respiratory sensitivity to ADP (i.e., lower
Kmapp) whether treated with protease inhibitors or protease (5 mmol/L trypsin, 30 min in permeabilization buffer). D: The respiratory Vmax in
permeabilized muscle bundles was significantly greater with BLEB in Buffer Z only. n 5 3, triplicate trials averaged. *Significantly different than
BLEB, P < 0.05; **P < 0.01; ***P < 0.001.
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effect of hyperoxia was independent of whether a contrac-
tion inhibitor was present or not (54). Similar data have
been obtained in human permeabilized muscle fiber bundles
(unpublished observation by C.G.R.P., D.A.K. and P.D.N.),
suggesting that O2 concentrations above air saturation are
not requisite for obtaining maximal O2 flux in permeabilized
muscle under these experimental conditions. However,
a significant impairment in Kmapp to ADP was reported with
hyperoxia at 30°C, so care must still be taken when con-
sidering the assay O2 concentrations (54).
IN VIVO APPROACHES: NUCLEAR MAGNETIC
RESONANCE
In most species, mitochondrial oxidative capacity is closely
matched to maximal O2 consumption (VO2max) measured in
vivo. Humans, however, are an interesting exception be-
cause mitochondrial respiratory capacity exceeds leg VO2
measured in vivo by arteriovenous O2 difference (135). This
apparent discrepancy between mitochondrial VO2max and
muscle VO2max was explained by limitations to O2 delivery to
the contracting skeletal muscle (135). This unique aspect of
human physiology has prompted careful scrutiny of meth-
ods to evaluate mitochondrial function in human skeletal
muscle. As discussed previously, experiments in isolated
mitochondria provide critical knowledge at the level of the
intact organelle, whereas experiments in permeabilized
muscle fibers are somewhat less reductionist by providing
a window into the capacity and function of the entire pop-
ulation of mitochondria in the tissue. A well-recognized
limitation of these in vitro methods is that measurements of
O2 consumption are made in the absence of the circulatory
system, a key limiter of VO2max in humans. For many years,
the Fick principle has been applied to measure leg VO2 from
measurements of blood flow and arteriovenous O2 differ-
ence, but a variety of noninvasive methods have emerged
more recently to evaluate mitochondrial capacity and
function in skeletal muscle in vivo. This section of the re-
view will provide a broad-strokes overview of several
magnetic resonance-based approaches that are quickly be-
coming widespread in use.
Oxidative capacity and basal ATP synthesis. A com-
mon premise to each method is that a target tissue is po-
sitioned within a static magnetic field such as a clinical
magnetic resonance imaging scanner. Within this magnetic
field, certain atoms (e.g., 1H, 13C, 31P) resonate at unique
frequencies when exposed to a second oscillating mag-
netic field. Nuclear magnetic resonance (NMR) spectros-
copy and magnetic resonance spectroscopy (MRS) are one
and the same, but the word “nuclear” is commonly dropped
to avoid the common misconception that the procedure
involves exposure to ionizing radiation. Phosphorous MRS
(31P-MRS) is a noninvasive technique that can be used to
monitor the levels of high-energy phosphates (e.g., ATP,
PCr) as well as other phosphorous-containing metabolites
(inorganic phosphate [Pi], phosphomonoesters, and phos-
phodiesters) in human skeletal muscle. A unique aspect
of 31P-MRS in skeletal muscle is the high signal-to-noise,
which permits rapid acquisition of spectra with temporal
resolution of several seconds or less. Chance et al. (136)
first applied 31P-MRS to investigate human skeletal muscle
bioenergetics in the 1980s. Thirty years earlier, Chance
and Williams (137) had established the regulatory role
of ADP in controlling mitochondrial respiration. Chance
applied the hyperbolic relationship between ADP and mi-
tochondrial respiration to predict skeletal muscle
oxidative capacity from 31P-MRS measurements made
during graded, progressive exercise (136). Owing to its
micromolar concentration and bound state, it is not cur-
rently possible to directly measure free ADP using 31P-
MRS in human muscle, but it can be calculated from the
concentrations of other measureable metabolites using
formulas described elsewhere (138). Chance showed that
mitochondrial oxidative capacity could be predicted in
vivo from a “transfer function” demonstrating a Michaelis-
Menten–type relationship between progressive work (or the
rate of respiration) and inorganic phosphate/PCr (ADP)
(139). A major challenge of this approach is accurate mea-
surement of muscle work and the critical assumption that
the workloads are truly steady state.
A simpler method involves predicting skeletal muscle
oxidative capacity using the kinetics of PCr recovery fol-
lowing a brief bout of muscle activity. During intense
muscle contractions, the creatine kinase reaction buffers
intracellular ATP levels at the expense of PCr, which falls
rapidly. During a recovery period after exercise, PCr is
resynthesized, and this repletion of PCr is a function of
mitochondrial ATP synthesis. Since the ATP generated
during recovery is driven primarily by oxidative metabo-
lism, the rate of PCr recovery is a commonly used in-
dicator of oxidative capacity (140–144). The assumption
that PCr resynthesis is a function of mitochondrial ATP
synthesis is supported by observations that PCr resyn-
thesis is absent when the muscle is kept ischemic follow-
ing muscle contraction, and PCr recovery occurs only
upon reperfusion of the limb (145). More recent studies
have shown some transient PCr resynthesis during ische-
mic recovery following muscle activity (146–148), owing to
the ever-improving signal-to-noise and temporal resolution
as magnetic resonance technology progresses. Notwith-
standing, the transient glycolytic contribution to PCr re-
synthesis exerts minimal influence on the rate constant
that defines PCr resynthesis over a 10-min recovery period.
It is important to note that during the recovery period after
exercise, the mitochondria are not working at their oxi-
dative capacity; rather, oxidative capacity can be predicted
from the rate at which PCr is regenerated. This approach
has been shown to be highly reproducible (149–152) and
well correlated with in vitro methods for assessing mito-
chondrial capacity (149,153,154). An advantage of this
approach compared with the transfer function is that ac-
curate measurement of muscle work is not necessary, but
major assumptions are that ATP concentrations are stable
and glycolytic flux is negligible during recovery.
Various approaches have been used to deplete PCr in
skeletal muscle, ranging from resting ischemia (155),
supramaximal stimulation of motor nerves (144), dynamic
voluntary contractions (151), submaximal isometric con-
tractions (150,153), and maximal voluntary contractions
(140,149). Transcutaneous nerve stimulation is an attractive
approach because the muscle can be maximally activated in
a way that overcomes potential limitations in voluntary
drive from higher centers. However, supramaximal motor
nerve stimulation may not be well tolerated by all patient
populations and poses a new set of challenges related
to noise injection from the stimulator/electromyography
cables breaching the shielded magnet room. Alternatively,
maximal voluntary contractions can be performed by most
patient populations. With sufficient habituation and visual
feedback provided by a computer monitor or series of light-
emitting diodes, it is possible to maximally activate skeletal
muscles with no limitations of central motor drive (assessed
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by superimposing electrical stimulation) (141). Although
submaximal contractions are sometimes used to deplete
PCr, the calculated oxidative capacity appears to be con-
sistently lower compared with maximal contractions
(150,151). The lower values derived from submaximal
efforts may result from incomplete motor unit recruitment if
the contraction intensity is below the threshold for com-
plete motor unit recruitment. It is also possible that motor
unit cycling during submaximal efforts could result in re-
cruitment of new motor units as the muscle begins to fa-
tigue while some initially recruited motor units no longer
contribute to force production. Either case is problematic
from the standpoint of measuring 31P metabolite levels by
MRS. A phosphorous spectrum represents the average sig-
nal of all of the tissue within the sampling volume of the
radiofrequency coil, regardless of whether the muscle is ac-
tive or not. Therefore, the changes in 31P metabolites in the
active muscle will be essentially “diluted” by the inactive
tissue. Although this issue can be avoided by using supra-
maximal stimulation or maximal voluntary contractions, one
drawback is that PCr recovery is influenced by intramuscular
pH. Careful attention is needed to ensure that the muscle
contraction is sufficient to deplete PCr without acidosis by
optimizing the duration of the exercise. Alternatively, it is
possible to model mitochondrial capacity from the recovery
rate of the calculated free ADP, which is independent of pH
(150,156). In sum, the kinetics of PCr (or ADP) recovery
following exercise is a reproducible, valid method to non-
invasively evaluate skeletal muscle oxidative capacity. This
approach, however, is restricted to skeletal muscle and
cannot be used to evaluate mitochondrial capacity in other
tissues such as liver, adipose, or brain.
In addition to measuring oxidative capacity, 31P-MRS
can be used to measure basal ATP synthesis rates using
magnetization-transfer techniques. The basic premise of
this approach is that it is possible to calculate metabolic
fluxes by perturbing the signal from a specific metabolite
(e.g., ATP) and monitoring how this perturbation is trans-
ferred to another metabolite (e.g., Pi, PCr) that is linked by
an exchange reaction (e.g., F1F0 ATPase, creatine kinase).
An advantage over the PCr recovery approach is that
magnetization transfer methods are not restricted to skele-
tal muscle tissues. There are several recent reviews that
provide excellent detail on the principles and practice of
this approach (157,158). An important point of emphasis
is that metabolic fluxes measured by magnetization trans-
fer are restricted to the steady-state conditions of resting
muscle and cannot be used to evaluate mitochondrial oxi-
dative capacity. Although the magnetization approach has
been widely used to evaluate mitochondrial function (159–
164), there continues to be lingering controversy over some
aspects of the data and its interpretation (158). The main
point of concern is that resting Pi→ATP flux measured
by 31P-MRS is ;10-fold higher than all other noninvasive
measures of resting oxidative ATP synthesis. As pointed out
by Kemp and Brindle (158), the exchange between Pi and
ATP at rest is dominated by glycolytic enzymes (glyceraldehyde-
3-phosphate dehydrogenase, phosphoglycerate kinase)
and should not be interpreted as an index of mitochon-
drial ATP synthesis. Others contend that the glycolytic
contribution is minimal at rest (165), and that the Pi→ATP
exchange scales as expected in mouse models in which
mitochondrial protein abundance is genetically altered
(166,167). The interested reader is pointed to several recent
articles in which these considerations are extensively
reviewed (157,158,168,169).
Mitochondrial coupling. The functionality of mitochon-
dria is often inferred from their capacity to consume O2 or
generate chemical energy. However, another important
aspect of mitochondrial physiology is the efficiency of
ATP synthesis by the organelles (i.e., coupling). Various
approaches have been used to evaluate bioenergetic effi-
ciency of isolated mitochondria (170) and in human skel-
etal muscle in vivo (171,172). This section of the review
will touch briefly on two distinct in vivo approaches that
have been applied to human skeletal muscle. The first
approach combines optical spectroscopy and MRS to si-
multaneously measure O2 consumption and ATP pro-
duction, respectively (155,171). The basic premise of this
approach is to determine the P/O by quantifying both
processes in parallel. Mitochondrial ATP synthesis is de-
termined from the decline in PCr concentrations in resting
ischemic muscle by 31P-MRS. During ischemia, mitochon-
drial ATP synthesis is suppressed and glycolytic ATP flux
is minimal (,8%) (155,171). In the absence of aerobic
or glycolytic ATP synthesis, intracellular PCr stores are
consumed at a rate that reflects the ATP demand of the
muscle. Mitochondrial ATP flux is determined using an
ATP balance approach that assumes equality between ATP
demand and mitochondrial ATP supply in resting muscle.
Other assumptions include that ischemia does not change
ATP demand, that glycolytic flux is negligible in resting
muscle, and that ischemia does not alter glycolytic flux
(155,171). Simultaneously, O2 consumption is measured in
vivo by near infrared spectroscopy during the first minute
of ischemia. A partial least squares analysis is used to
differentiate between hemoglobin and myoglobin desatu-
ration during ischemia. From these independent pieces of
data acquired during ischemia, it is possible to determine
the ratio of net ATP turnover to O2 uptake as a measure of
mitochondrial bioenergetic efficiency. Although the 31P-MRS
component is relatively straightforward, the measurement
of O2 uptake requires substantial technical expertise, in
vitro calibration sets, wavelength shift analysis to deter-
mine the ratio of different chromophores, and ability to
measure deoxymyoglobin by proton MRS.
Another noninvasive NMR technique to evaluate bio-
energetic efficiency of mitochondria involves measuring
basal ATP flux by magnetization transfer paired with TCA
flux measured by 13C-MRS (157,168,172). This approach
deviates somewhat from the conventional definition of
mitochondrial coupling at the level of the cytochrome
chain; rather, it assesses efficiency from the ratio of sub-
strate oxidation in the TCA to ATP synthesis. Assessment
of TCA flux is made by infusing a magnetic resonance–
visible tracer, [2-13C] acetate, which enters the TCA after
it is converted to acetyl CoA. Although the TCA inter-
mediates are not present in sufficiently high concen-
trations to be directly measured by 13C-MRS, it is possible
to monitor the time course of 13C enrichment of glutamate,
which exchanges rapidly with a-ketoglutarate. At this point,
sophisticated modeling is required to determine the meta-
bolic fate of the labeled acetate molecule. The details of this
modeling are beyond the scope of this review, but are nicely
detailed elsewhere (157,168,172). By pairing TCA flux with
basal ATP synthesis measured by 31P-MRS magnetization
transfer, it is possible to evaluate the efficiency of mito-
chondria, by comparing the level of substrate oxidation at
a given level of basal ATP flux. Similar to the P/O mea-
surements described above, this approach also requires
substantial technical expertise, mathematical modeling, and
careful attention to assumptions. It is important to note that
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this estimate of mitochondrial efficiency differs from the
more traditional direct measurements of phosphorylation
efficiency measured in vitro by high-resolution respirom-
etry or in vivo by the combination of optical spectroscopy
and 31P-MRS described above. Nevertheless, all of the
approaches described here represent theoretically plausi-
ble methods to evaluate aspects of mitochondrial coupling
or efficiency, but as with any method, careful attention
must be given to underlying critical assumptions.
PERSPECTIVES AND CONCLUSIONS
To summarize, it is clear that a variety of experimental
parameters and/or modeling approaches must be carefully
considered in the context of the specific hypothesis being
tested. Each method provides a unique set of advantages as
well as limitations. The purest way to assess mitochondrial
function free from other factors is to isolate mitochondria
from the local environment, but this requires extensive
disruption of mitochondrial structure and morphology with
considerable loss of sample. Mitochondrial structure can be
largely retained through simple chemical permeabilization
of cell membranes providing access to mitochondrial com-
partments free from soluble cytoplasmic factors. However,
numerous experimental parameters must be carefully
controlled, and classic approaches for assessing certain
bioenergetic parameters in isolated mitochondria (e.g.,
membrane potential) have not been fully developed in per-
meabilized tissue. Interestingly, combining multiple ap-
proaches may yield significant insight into the regulation of
mitochondrial bioenergetics. For example, comparing the
function of isolated mitochondria versus permeabilized
samples is a powerful approach to determine the role of
mitochondrial morphology or local structures in regulating
mitochondrial function. Recent technological advances now
permit assessment of respiratory control in intact adherent
cultured cells, offering the opportunity for high through-put
analyses in this specific model. Lastly, NMR is the most direct
method for assessing mitochondrial function in vivo, espe-
cially in humans. Mathematical models have specifically
targeted energetic components of mitochondrial function,
with a focus on oxidative capacity, basal ATP synthesis, and
coupling, which can be measured in real time. Ongoing
developments in algorithms and conceptual assumptions
have enhanced the power of this approach. The rapid prog-
ress of these technologies and approaches has expanded
opportunities to investigate the potential contribution of mi-
tochondrial bioenergetics and redox systems biology to the
etiology of type 2 diabetes.
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